Showing results (411-420 of 539) with videos related to

Sort By:
Pageof 54
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Optimizing bispecific antibody pretargeting for use in radioimmunotherapyRobert M Sharkey, Habibe Karacay, Heidi Richel, et al.
The Journal of Biological Chemistry|April 5, 2012
Interaction of voltage-gated sodium channel Nav1.6 (SCN8A) with microtubule-associated protein Map1bJanelle E O'Brien, Lisa M Sharkey, Christina N Vallianatos, et al.
Clinical Genitourinary Cancer|November 7, 2015
Sacituzumab Govitecan, a Novel Antibody--Drug Conjugate, in Patients With Metastatic Platinum-Resistant Urothelial CarcinomaBishoy Faltas, David M Goldenberg, Allyson J Ocean, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
Radioimmunotherapy of medullary thyroid cancer with iodine-131-labeled anti-CEA antibodiesM Juweid, R M Sharkey, T Behr, et al.
Nature Medicine|November 1, 2005
Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibodyRobert M Sharkey, Thomas M Cardillo, Edmund A Rossi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Therapeutic advantage of pretargeted radioimmunotherapy using a recombinant bispecific antibody in a human colon cancer xenograftHabibe Karacay, Pierre-Yves Brard, Robert M Sharkey, et al.
Annals of the New York Academy of Sciences|December 17, 2013
Circadian clocks, brain function, and developmentEllen Frank, Michelle M Sidor, Karen L Gamble, et al.
Bioconjugate Chemistry|January 3, 2014
Anti-CEA antibody fragments labeled with [(18)F]AlF for PET imaging of CEA-expressing tumorsS Lütje, G M Franssen, R M Sharkey, et al.
Frontiers in Pharmacology|April 16, 2015
A pretargeting system for tumor PET imaging and radioimmunotherapyFrançoise Kraeber-Bodéré, Caroline Rousseau, Caroline Bodet-Milin, et al.
Pageof 54